Mar 30, 2017: Logistics provider Kuehne + Nagel and pharmaceutical research company Grünenthal agree global partnership for land, air and sea freight. Kuehne + Nagel is supporting the Grünenthal Group with the reorganisation of the worldwide transportation network for highly sensitive pharmaceutical products.
Kuehne + Nagel and Grünenthal are working together to develop a solution that is tailored to the requirements of the Grünenthal Group with KN PharmaChain as its core element. KN PharmaChain is a multi-modal logistics solution for temperature-controlled door-to-door transportation which allows accurate traceability of the deliveries and intensive, proactive risk management. Kuehne + Nagel recently became the first logistics provider worldwide to receive the IATA CEIV Pharma certification for the KN PharmaChain network covering 86 locations. The certification helps ensure the integrity of pharmaceutical products throughout the entire airfreight supply chain.
Victor Barbosa, senior vice president, Global Supply Chain, Grünenthal, said, "With this new agreement, we were able to combine all our global forwarding services with the Kuehne + Nagel Group. This centralisation and our partner's expertise in the pharmaceutical industry will help us to make our processes more efficient and enhance our competitiveness."
Hansjörg Rodi, managing director, Kuehne + Nagel Germany, said, “We are delighted with the confidence the Grünenthal Group has placed in us and look forward to future collaboration. Our aim is to reshape the entire network for logistics services together with the customer. To achieve this, we will utilise our expertise in providing services for the pharmaceutical and healthcare industry, which is of strategic importance for Kuehne + Nagel.”
In addition to the conceptual development of the network, the agreement involves integrated logistics services such as network and stock management and the global transportation of temperature-controlled products by sea, air and land.